Vasculitis: Clinical Trials

6 trials for Vasculitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 terminated. 6 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 46Terminated 6

Follow Vasculitis: new trials by email Literature Review of Vasculitis trials Research Report on Vasculitis

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Hydroxychloroquine in ANCA Vasculitis Evaluation
Hydroxychloroquine, Placebo - ANCA Associated Vasculitis, Microscopic Polyangiitis
Phase 4TerminatedGuy's and St Thomas' NHS Foundation Trust432020-12-172026-04-29
Maintenance of ANCA Vasculitis Remission by Intermittent Rituximab Dosing
Rituximab - Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Phase 4TerminatedMassachusetts General Hospital1152016-06-012023-07-27
Rituximab for the Otolaryngologic Manifestations of Granulomatosis With Polyangiitis
Rituximab, Placebo - Granulomatosis With Polyangiitis (Wegener's Granulomatosis)
Phase 4TerminatedHospital for Special Surgery, New York32015-12-012018-03-22
Interventional Cryotherapy for the Eradication of Benign Airway Disease ("ICE the BAD")
CryoSpray Ablation - Lung Diseases, Obstructive, Sarcoidosis
Phase 4TerminatedCSA Medical, Inc.52008-10-012015-08-18
Prolonging the Duration of Peripheral Venous Catheters in Cystic Fibrosis People
regular dilution of antibiotic in NS, higher dilution of antibiotic in NS - Cystic Fibrosis, Phlebitis
Phase 4TerminatedUniversity of Florence602007-03-012015-10-29
Prevention of Relapses in Proteinase 3 (PR3)-Anti-neutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis
azathioprine - Vasculitis
Phase 4TerminatedUniversity Medical Center Groningen1312003-06-012018-12-13

Narrower conditions

Granulomatosis with Polyangiitis (4)  ·  Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (3)  ·  Churg-Strauss Syndrome (1)  ·  Cystic Fibrosis (1)  ·  Lung Diseases, Obstructive (1)  ·  Microscopic Polyangiitis (1)  ·  Phlebitis (1)  ·  Recurrent respiratory papillomatosis (1)  ·  Rhinoscleroma (1)  ·  Sarcoidosis (1)

Broader conditions

Cardiovascular Diseases (6)  ·  Vascular Diseases (6)  ·  Autoimmune Diseases (5)  ·  Immune System Diseases (5)  ·  Lung Diseases (5)  ·  Respiratory Tract Diseases (5)  ·  Skin Diseases (5)  ·  Skin Diseases, Vascular (5)  ·  Skin and Connective Tissue Diseases (5)  ·  Systemic Vasculitis (5)  ·  Lung Diseases, Interstitial (4)  ·  Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (2)  ·  Hemic and Lymphatic Diseases (2)  ·  Lymphatic Diseases (2)

Interventions

Rituximab (2)  ·  Azathioprine (1)  ·  Cryoelectron Microscopy (1)  ·  Cryosurgery (1)  ·  Cryotherapy (1)  ·  Hydroxychloroquine (1)

Sponsors

CSA Medical, Inc. (1)  ·  Guy's and St Thomas' NHS Foundation Trust (1)  ·  Hospital for Special Surgery, New York (1)  ·  Massachusetts General Hospital (1)  ·  University Medical Center Groningen (1)  ·  University of Florence (1)

Countries

United States (3)  ·  Italy (1)  ·  Netherlands (1)  ·  United Kingdom (1)

Top investigators

Coen A Stegeman, MD, PhD (1)  ·  David D'Cruz (1)  ·  Filippo Festini, RN, BA, BSN (1)  ·  John L Niles, MD (1)  ·  Michael Machuzak, M.D. (1)  ·  Robert F Spiera, MD (1)

Results publications

PMID 27242368, PMID 37024906, PMID 38123922

NIH funding

2018 (1)